Adeno-associated virus (AAV) vectors are widely used in gene therapy due to their ability to deliver genetic material effectively into host cells. These non-pathogenic viruses can transduce both dividing and non-dividing cells, making them ideal for treating various genetic disorders. Their safety profile and long-term expression capabilities further enhance their therapeutic potential.